Next Article in Journal
Regulation of Root Development and Architecture by Strigolactones under Optimal and Nutrient Deficiency Conditions
Next Article in Special Issue
Application of Nanoparticles for Targeting G Protein-Coupled Receptors
Previous Article in Journal
Comparative Transcriptome Analysis Identifies Genes Putatively Involved in 20-Hydroxyecdysone Biosynthesis in Cyanotis arachnoidea
Previous Article in Special Issue
The Effect of GPRC5a on the Proliferation, Migration Ability, Chemotherapy Resistance, and Phosphorylation of GSK-3β in Pancreatic Cancer
Article Menu
Issue 7 (July) cover image

Export Article

Open AccessReview

GPCRs in Cancer: Protease-Activated Receptors, Endocytic Adaptors and Signaling

1
Biomedical Sciences Graduate Program, School of Medicine, University of California, La Jolla, San Diego, CA 92093, USA
2
Department of Pharmacology, School of Medicine, University of California, La Jolla, San Diego, CA 92093, USA
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work, and both are first co-authors.
Int. J. Mol. Sci. 2018, 19(7), 1886; https://doi.org/10.3390/ijms19071886
Received: 1 May 2018 / Revised: 20 June 2018 / Accepted: 21 June 2018 / Published: 27 June 2018
(This article belongs to the Special Issue Cancer-Driver G Protein-Coupled Receptors as Therapeutic Targets)
  |  
PDF [1638 KB, uploaded 27 June 2018]
  |  

Abstract

G protein-coupled receptors (GPCRs) are a large diverse family of cell surface signaling receptors implicated in various types of cancers. Several studies indicate that GPCRs control many aspects of cancer progression including tumor growth, invasion, migration, survival and metastasis. While it is known that GPCR activity can be altered in cancer through aberrant overexpression, gain-of-function activating mutations, and increased production and secretion of agonists, the precise mechanisms of how GPCRs contribute to cancer progression remains elusive. Protease-activated receptors (PARs) are a unique class of GPCRs implicated in cancer. PARs are a subfamily of GPCRs comprised of four members that are irreversibly activated by proteolytic cleavage induced by various proteases generated in the tumor microenvironment. Given the unusual proteolytic irreversible activation of PARs, expression of receptors at the cell surface is a key feature that influences signaling responses and is exquisitely controlled by endocytic adaptor proteins. Here, we discuss new survey data from the Cancer Genome Atlas and the Genotype-Tissue Expression projects analysis of expression of all PAR family member expression in human tumor samples as well as the role and function of the endocytic sorting machinery that controls PAR expression and signaling of PARs in normal cells and in cancer. View Full-Text
Keywords: invasion; metastasis; breast cancer; arrestins; ARRDC3; lysosomes invasion; metastasis; breast cancer; arrestins; ARRDC3; lysosomes
Figures

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Arakaki, A.K.S.; Pan, W.-A.; Trejo, J. GPCRs in Cancer: Protease-Activated Receptors, Endocytic Adaptors and Signaling. Int. J. Mol. Sci. 2018, 19, 1886.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top